Epperly Melissa B,

Epperly Melissa B, is listed in filings as Director at Roivant Sciences Ltd. - Common Shares. This profile follows SEC Form 4 activity through Apr 21, 2026, including sale activity. Recent filings connect the profile to Roivant Sciences Ltd. - Common Shares (ROIV) and Nautilus Biotechnology, Inc. (NAUT). The current snapshot covers public activity from Jun 17, 2024 to Apr 21, 2026. Reported amounts are shown as $1.2M to $464.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.